In a bold pivot toward healthcare services, Costco has announced that it will offer Ozempic and Wegovy — two popular injectable drugs based on semaglutide — at 50% off their usual price for members who pay out-of-pocket.

That is, a four-week supply of the injectable pens will cost about $499 under the Costco Member Prescription Program, rather than the full retail price. The discount applies to members who present a valid prescription and pay directly (i.e. uninsured or self-pay).

Costco’s executive members and those with a Costco Citibank Visa card may also get an additional 2% discount on top of the reduced rate.

This change arises from a collaboration between Costco and Novo Nordisk, the pharmaceutical company that markets Ozempic and Wegovy. The partnership is intended to make these FDA-approved drugs more accessible, reducing cost barriers and helping customers avoid counterfeit or unregulated sources.

The Background: Ozempic, Wegovy & Soaring Demand

Ozempic was originally approved for managing type 2 diabetes; Wegovy, a close relative, is specifically approved as a weight-loss medication (for obesity management). Both share the same active ingredient (semaglutide) and are part of a class called GLP-1 receptor agonists, which affect appetite, satiety, and metabolic regulation.

In recent years, demand for these medications has surged. Many people have sought them for weight management even if they don’t have diabetes, pushing prices and interest upward. The high demand has also contributed to a rise in counterfeit or off-label versions circulating in unregulated markets — which presents safety risks.

Meanwhile, Novo Nordisk has already taken steps to reduce the cost for uninsured patients: for example, they announced a program setting Wegovy’s cash price at $499 per month for patients lacking insurance coverage. This helps illustrate a broader push to expand access beyond conventional insurance pathways.

Why Costco? Why Now?

There are several reasons why Costco’s entry into discounted weight-loss drugs is strategically significant:

• Trusted retailer platform: Many consumers already see Costco as a low-cost, high-trust shopping destination. Adding pharmaceutical discounts fits into that value narrative.

• Eliminating intermediaries: Selling drugs directly (or through the Costco prescription program) can reduce markups and middlemen costs, allowing manufacturers and Costco to share savings with consumers.

• Meeting unmet demand: With so much public interest in weight-loss medications, especially GLP-1s, this move allows Costco to capture a portion of a rapidly growing market.

• Brand differentiation: Offering this kind of health benefit (beyond groceries and bulk goods) helps Costco distinguish itself further in retail and membership value.

What This Means for Consumers

Pros / Opportunities

• Lower cost barrier: For people who cannot access coverage through insurance, $499 for a month is much more affordable than traditional pricing.

• Access to authentic product: Because Costco is working directly with the drugmaker, customers are more likely to receive FDA-approved pens rather than counterfeit alternatives.

• Transparent pricing: The price is fixed and public, so customers know upfront what they’ll pay — no hidden markup surprises.

Caveats / Considerations

• Prescription required: Even with the discount, you can’t just walk in and pick up a pen — a valid prescription is needed.

• Insurance coverage complexities: Many insurance plans do not cover GLP-1 weight-loss drugs for non-diabetes use, so the discount benefits primarily those paying out-of-pocket.

• Not a cure-all: These medications can support weight loss, but they must be used under medical supervision, with lifestyle support (diet, exercise). They also have side effects and contraindications.

• Sustainability & supply: High demand and supply constraints could challenge consistent availability. Also, the pricing model may evolve.

• Geographic limits: The announced discount is U.S.-focused; depending on where you live, this program may or may not apply.

Looking Ahead: Industry & Policy Impact

Costco’s move reflects broader trends shaking up the pharmaceutical and retail worlds:

• Drugmakers are exploring direct-to-consumer models and discount programs to bypass some traditional middlemen and reduce patient cost burdens.

• Big retail chains are increasingly entering healthcare vertically — Amazon, Walmart, and now Costco are using their scale and trust to offer medical services or discounted prescription access.

• Policymakers are under more pressure to control prescription drug costs. Moves like this could influence future regulation, negotiations, or price setting for medications.

In short, this development could help signal change in how we buy, distribute, and regulate high-demand specialty medications.

Final Thoughts

Costco’s decision to offer Ozempic and Wegovy at half price for members with prescriptions is a bold and potentially game-changing move. For many, it could bridge a gap between an effective treatment and financial inaccessibility. But it also raises questions about coverage, equity, and the long-term sustainability of such pricing models.

If you’re considering one of these medications, it’s essential to consult a qualified healthcare provider to see whether it’s appropriate, safe, and supported by your particular health profile.